Singapore markets open in 55 minutes

Ocular Therapeutix, Inc. (0OT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
5.20-0.51 (-8.89%)
At close: 04:05PM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4455
Avg. Estimate-0.25-0.22-0.65-0.69
Low estimate-0.3-0.29-1.12-0.95
High estimate-0.2-0.14-0.41-0.33
Year ago EPS-0.21-1.21-2.56-0.65
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6677
Avg. Estimate13.59M16.9M49.34M96.79M
Low estimate9.5M10.38M38.94M54.28M
High estimate15.72M20.74M55.52M118.2M
Year ago sales5.49M7.35M17.4M49.34M
Sales growth (year/est)147.50%130.00%183.50%96.20%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.24-0.17-0.21-0.21
Actual EPS-0.21-1.210.04-0.11
Difference0.03-1.040.250.1
Surprise %12.50%-611.80%119.00%47.60%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.25-0.22-0.65-0.69
7 days ago-0.25-0.22-0.65-0.69
30 days ago-0.25-0.22-0.63-0.68
60 days ago-0.19-0.16-0.64-0.4
90 days ago-0.19-0.15-0.76-0.39
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates0OT.FIndustrySector(s)S&P 500
Current qtr.-19.00%N/AN/AN/A
Next qtr.81.80%N/AN/AN/A
Current year74.60%N/AN/AN/A
Next year-6.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A